Pfizer Ready to Submit Vaccine Data for Youth Soon – Daily Access News
Coronavirus (COVID-19)Health

Pfizer Ready to Submit Vaccine Data for Youth Soon

US Eases Some International Travel Restrictions

A A A
Many parents across the US are celebrating the announcement that their young children may soon be eligible to receive the COVID-19 vaccine. Here is the latest in the fight against the dangerous virus.

Pfizer Makes Important Vaccine Announcement

Pfizer announced on Monday that the latest Phase 2/3 trial demonstrated that its COVID-19 vaccine was safe and effective for children in the age group ranging from 5 to 11. The announcement marks the first time that official results have been results for this age group for a US vaccine. According to Pfizer, they will submit the data to the US Food and Drug Administration (FDA) for emergency use authorization (EUA) shortly. From there, it would likely only take a few weeks for the FDA to recommend the vaccine for widespread use.

Details of Trial

Read More »
Tags

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close
Close
x

Newsletter

Get a daily email of trending news and updates. Be the first to see top stories and events.